Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone

Trial ID or NCT#

NCT04676802

Status

recruiting iconRECRUITING

Purpose

In the US, pain management after surgery for surgical treatment of osteoarthritis at the base of the thumb typically consists of prescription opioids during the early recovery phase. Given the highly addictive nature of prescription opioids, guidelines are being evaluated by hand surgeons to reduce opioid use while still maintaining pain control after surgery. A promising approach is to use non-narcotic medication as the first line of treatment. The purpose of this study is to demonstrate the efficacy of a combination of non-steroidal anti-inflammatory drugs (NSAIDs), ibuprofen and acetaminophen, in comparison to a morphine analogue substance (oxycodone) for pain management in the first 30 days after surgery.

Official Title

Pain Relief After Trapeziectomy Without Opioids: Ibuprofen & Acetaminophen Versus Oxycodone

Eligibility Criteria

Ages Eligible for Study: Older than 45 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. * Undergoing trapeziectomy for thumb osteoarthritis
    1. English proficient,
Exclusion Criteria:
  1. * Pregnancy
    1. Current use of opioids
    2. Concurrent surgeries (ex. trapeziectomy combined with carpal tunnel release)
    3. Inability to complete study forms (education, cognitive ability, mental status, medical status)
    4. Allergy or intolerance to Ibuprofen, Acetaminophen and/or Oxycodone
    5. Liver or kidney dysfunction, abnormal liver enzymes restricting use of acetaminophen or ibuprofen
    6. History of chronic heart failure, upper gastrointestinal bleeding or coagulopathy
    7. History of complex regional pain syndrome
View All Criteria
Show Less

Investigator(s)

Amy Ladd, MD
Amy Ladd, MD
Hand and upper extremity surgeon
Elsbach-Richards Professor of Surgery and Professor, by courtesy, of Medicine (Immunology & Rheumatology) and of Surgery (Plastic and Reconstructive Surgery)
SEND MESSAGE

View on ClinicalTrials.gov